In stock
Caffate 20 mg/ml Solution for infusion and oral solution 3ml Vial 10pcs
In stock
Only 1 left
SKU
10331014228
Caffate 20 mg/ml Solution is an essential medication for treating apnea of prematurity in infants. This solution, containing Caffeine Citrate, helps stimulate breathing in premature newborns and can be administered orally or via infusion. It comes in a pack of 10 vials, each containing 3ml.
Product Overview
Caffate 20 mg/ml Solution for infusion and oral solution is a critical medication designed for the management of apnea of prematurity in infants.
Containing Caffeine Citrate as its active ingredient, this solution works by stimulating the central nervous system to reduce the incidence of breathing pauses in premature newborns.
Available in convenient 3ml vials, Caffate offers flexibility for both intravenous infusion and oral administration, providing essential support for vulnerable infants.
Benefits of Use
- Effective treatment for apnea of prematurity, a common condition in premature infants.
- Reduces the frequency and severity of apneic episodes, promoting more stable breathing patterns.
- Improves overall respiratory stability in premature newborns.
- Can be administered either intravenously for rapid action or orally for sustained treatment, offering clinical flexibility.
- Supports better oxygenation and reduces the need for mechanical ventilation in some cases.
How to Use
Caffate solution should only be administered by a healthcare professional experienced in the care of premature infants.
The dosage and administration route will be determined based on the infant's weight, gestational age, and clinical response.
- Ensure sterile technique when preparing for administration, especially for infusion.
- The solution can be given orally using an appropriate dosing syringe, or intravenously after dilution according to medical guidelines.
- Follow the precise dosage instructions provided by your physician or neonatologist.
- Monitor the infant closely for therapeutic effects and potential side effects during treatment.
Caution & Warnings
- Caffate 20 mg/ml is a prescription-only medication and must be used under strict medical supervision.
- Close monitoring for signs of caffeine toxicity (e.g., tachycardia, arrhythmias, gastrointestinal disturbances, tremors, restlessness) is essential.
- Use with caution in infants with cardiac disease, renal impairment, or seizures.
- Avoid concomitant use with other xanthine derivatives without medical advice.
- Ensure accurate dosing to prevent overdose, which can lead to serious adverse effects.
- Keep out of reach of children. Store as directed by the manufacturer.
Ingredients
- Active Ingredient: Caffeine Citrate 20 mg/ml
Product Details
- Brand: Caffate
- Manufacturer: PharmaSwiss (part of Bausch Health)
- Dosage Form: Solution for infusion and oral solution
- Strength: 20 mg/ml
- Package Size: 10 x 3ml Vials
| Gtin | 912246380 |
|---|---|
| Recommended Sale Price | 2247.9 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | CAFFEINE CITRATE |
| SFDA Reg. No | 912246380 |
| IBC | 912246380 |
| Drug Type | Prescription |
| Scientific Name | Caffeine Citrate |
| Strength | 20 |
| Strength Unit | mg/ml |
| Form | Solution for infusion and oral solution |
| Admin Route | Oral, Intravenous |
| Size | 3 |
| Size Unit | ml |
| Package Types | Vials |
| Package Size | 10 vials |
| Storage conditions | Store below 25C. Do not freeze. Protect from light. |
| Refrigerator Storage | No |
| Distribute area | Saudi Arabia, Egypt |
Products you might like
